{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:21:34Z","timestamp":1793366494067,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007937","name":"Peking University, First Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ygyno.2020.07.102","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T08:13:05Z","timestamp":1597219985000},"page":"36-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["POLE mutation combined with microcystic, elongated and fragmented (MELF) pattern invasion in endometrial carcinomas might be associated with poor survival in Chinese women"],"prefix":"10.1016","volume":"159","author":[{"given":"Dan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conghui","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2020.07.102_bb0005","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1016\/S1470-2045(13)70591-6","article-title":"Classification of endometrial carcinoma: more than two types","volume":"15","author":"Murali","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2020.07.102_bb0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2020.07.102_bb0015","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1101\/gr.174789.114","article-title":"Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication","volume":"24","author":"Shinbrot","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.ygyno.2020.07.102_bb0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrc.2015.12","article-title":"A panoply of errors: polymerase proofreading domain mutations in cancer","volume":"6","author":"Rayner","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ygyno.2020.07.102_bb0025","first-page":"402","article-title":"Prognostic significance of POLE proofreading mutations in endometrial cancer","volume":"107","author":"Church","year":"2015","journal-title":"J. Natl. Cancer I"},{"key":"10.1016\/j.ygyno.2020.07.102_bb0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2014.05.006","article-title":"POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium","volume":"134","author":"Meng","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.07.102_bb0035","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1158\/1078-0432.CCR-15-2233","article-title":"Endometrial carcinomas with POLE exonuclease domain mutations have a favorable prognosis","volume":"22","author":"McConechy","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2020.07.102_bb0040","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/his.12878","article-title":"Histopathological features of endometrial carcinomas associated with POLE mutations: implications for decisions about adjuvant therapy","volume":"68","author":"Bakhsh","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.ygyno.2020.07.102_bb0045","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ejca.2015.05.015","article-title":"Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer\u2013a pooled analysis of PORTEC 1 and 2 trials 51","volume":"13","author":"Bosse","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.07.102_bb0050","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1525-1438.2007.00996.x","article-title":"The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology","volume":"2","author":"Chi","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2020.07.102_bb0055","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/01.pgp.0000092161.33490.a9","article-title":"Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance","volume":"22","author":"Murray","year":"2003","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2020.07.102_bb0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2559.2009.03327.x","article-title":"Immunophenotypic features of MELF pattern invasion in endometrial adenocarcinoma: evidence for epithelialmesenchymal transition","volume":"55","author":"Stewart","year":"2009","journal-title":"Histopathology."},{"key":"10.1016\/j.ygyno.2020.07.102_bb0065","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/modpathol.2009.33","article-title":"Expression of cell cycle regulatory proteins in endometrial adenocarcinoma: variations in conventional tumor areas and in microcystic, elongated and fragmented glands","volume":"22","author":"Stewart","year":"2009","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2020.07.102_bb0070","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/PGP.0b013e3181e4ee4ea","article-title":"Galectin-3 expression in uterine endometrioid adenocarcinoma: comparison of staining in conventional tumor glands and in areas of MELF pattern myometrial invasion","volume":"29","author":"Stewart","year":"2010","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2020.07.102_bb0075","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/PGP.0b013e3182158944","article-title":"Cytokeratin 19 expression in normal endometrium and in low-grade endometrioid adenocarcinoma of the endometrium","volume":"30","author":"Stewart","year":"2011","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2020.07.102_bb0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2559.2011.03893.x","article-title":"Fascin expression in low-grade uterine endometrioid adenocarcinoma; correlation with MELF type alteration at the deep invasive margin","volume":"59","author":"Stewart","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.ygyno.2020.07.102_bb0085","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.prp.2010.10.005","article-title":"CD147 (EMMPRIN) and matrix metalloproteinase-2 expression in uterine endometrioid adenocarcinoma","volume":"207","author":"Stewart","year":"2011","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.ygyno.2020.07.102_bb0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/his.12057","article-title":"Epithelial-mesenchymal transition in carcinomas of the female genital tract","volume":"62","author":"Stewart","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.ygyno.2020.07.102_bb0095","series-title":"WHO Clasification of Tumours of Female Reproductive Organs","first-page":"126","volume":"vol. 5","author":"Kurman","year":"2014"},{"key":"10.1016\/j.ygyno.2020.07.102_bb0100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijgo.2009.02.010","article-title":"Revised FIGO staging for carcinoma of the endometrium","volume":"105","author":"Creasman","year":"2009","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.ygyno.2020.07.102_bb0105","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/cncr.29046","article-title":"Polymerase varepsilon (POLE) mutations in endometrial cancer: clinical outcomes and implications for Lynch syndrome testing","volume":"121","author":"Billingsley","year":"2015","journal-title":"Cancer."},{"key":"10.1016\/j.ygyno.2020.07.102_bb0110","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ygyno.2017.10.037","article-title":"An NRG Oncology\/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer","volume":"148","author":"Cosgrove","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.07.102_bb0115","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/modpathol.2015.43","article-title":"Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative","volume":"28","author":"Stelloo","year":"2015","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2020.07.102_bb0120","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/PGP.0000000000000384","article-title":"Microcystic, elongated, and fragmented pattern invasion in ovarian endometrioid carcinoma: immunohistochemical profile and prognostic implications","volume":"37","author":"Goldberg","year":"2018","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2020.07.102_bb0125","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1093\/hmg\/ddt131","article-title":"DNA polymerase \u03b5 and \u03b4 exonuclease domain mutations in endometrial cancer","volume":"22","author":"Church","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ygyno.2020.07.102_bb0130","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jamaoncol.2015.2151","article-title":"Association of Polymerase e-mutated and microsatellite-instable endometrial cancers with neoantigen load, number of tumor-infiltrating lymphocytes, and expression of PD-1 and PD-L1","volume":"1","author":"Howitt","year":"2015","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ygyno.2020.07.102_bb0135","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1158\/1078-0432.CCR-0732-3","article-title":"Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma","volume":"10","author":"Kondratiev","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2020.07.102_bb0140","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejogrb.2018.09.036","article-title":"MELF pattern of myometrial invasion and role in possible endometrial cancer diagnostic pathway: a systematic review of the literature","volume":"230","author":"Prodromidoua","year":"2018","journal-title":"Eur. J. Obstet. Gyn. R. B."},{"key":"10.1016\/j.ygyno.2020.07.102_bb0145","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/PAS.0000000000000754","article-title":"The microcystic, elongated, and fragmented (MELF) pattern of invasion a single institution report of 464 consecutive FIGO grade 1 endometrial endometrioid adenocarcinomas","volume":"41","author":"Joehlin-Price","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2020.07.102_bb0150","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/PAS.0000000000000856","article-title":"Clinicopathologic association and prognostic value of microcystic, elongated, and fragmented (MELF) pattern in endometrial endometrioid carcinoma","volume":"41","author":"Kihara","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2020.07.102_bb0155","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12307-018-0213-5","article-title":"Tumor-associated T-lymphocytes and macrophages are decreased in endometrioid endometrial carcinoma with MELF-pattern stromal changes","volume":"11","author":"Zinovkin","year":"2018","journal-title":"Cancer Microenviron."},{"key":"10.1016\/j.ygyno.2020.07.102_bb0160","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ygyno.2016.11.023","article-title":"Polymerase \u03b5 (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro","volume":"144","author":"Bellone","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.07.102_bb0165","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/modpathol.2014.143","article-title":"Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations","volume":"28","author":"Hussein","year":"2015","journal-title":"Modern Pathol."},{"key":"10.1016\/j.ygyno.2020.07.102_bb0170","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/PGP.0000000000000243","article-title":"TP53 mutational spectrum in endometrioid and serous endometrial cancers","volume":"35","author":"Schultheis","year":"2016","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2020.07.102_bb0175","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2020.07.102_bb0180","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/annonc\/mdy058","article-title":"Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series","volume":"29","author":"Kommoss","year":"2018","journal-title":"Ann. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820337525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820337525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:49:57Z","timestamp":1758772197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825820337525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0090825820337525"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.07.102","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"POLE mutation combined with microcystic, elongated and fragmented (MELF) pattern invasion in endometrial carcinomas might be associated with poor survival in Chinese women","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.07.102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}